A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Fluorouracil (5-FU) in Patients With Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine
Phase of Trial: Phase III
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Glufosfamide (Primary) ; Fluorouracil
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Registrational; Therapeutic Use
- Sponsors Eleison Pharmaceuticals
- 23 Feb 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 23 Feb 2017 Planned primary completion date changed from 1 May 2017 to 1 Sep 2018.
- 05 May 2016 According to an Eleison Pharmaceuticals media release, the China Food and Drug Administration (CFDA) has approved enrollment of patients in China under this trial.